Author

Nanang Rudianto Ariefta

National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary MedicineORCID 0000-0002-3012-6005Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Eloiza May GaloniD· 1 shared Hang Li· 1 shared Lijun Jia· 1 shared Masahito AsadaiD· 1 shared Miako SakaguchiiD· 1 shared Mingming LiuiD· 1 shared Shengwei JiiD· 1 shared Shimaa AES El-Sayed· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Eloiza May GalonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Efficacy and mechanism of action of cipargamin as an antibabesial drug candidate

Hang Li, Shengwei Ji, Nanang Rudianto Ariefta, Eloiza May Galon, Shimaa AES El-Sayed, Thom Do, Lijun Jia, Miako Sakaguchi, Masahito Asada, Yoshifumi Nishikawa, Xin Qin, Mingming Liu, Xuenan Xuan

This study evaluates cipargamin's efficacy against Babesia species and identifies resistance mechanisms, showing its effectiveness as an anti-babesial drug but limitations due to resistance, with combination therapy with tafenoquine offering potential.

eLife · Jun 2, 2025Peer-reviewedMicrobiology